{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:53:16Z","timestamp":1791816796233,"version":"4.3.4"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10947-9","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T13:33:20Z","timestamp":1756215200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rho kinase isoforms in neurodegeneration: from cellular functions to therapeutic targets"],"prefix":"10.1007","volume":"52","author":[{"given":"Chesta","family":"Shandilya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"42","key":"10947_CR1","doi-asserted-by":"publisher","first-page":"8200","DOI":"10.1523\/jneurosci.1157-19.2019","volume":"39","author":"V Rangaraju","year":"2019","unstructured":"Rangaraju V, Lewis TL, Hirabayashi Y, Bergami M, Motori E, Cartoni R, Kwon S, Courchet J (2019) Pleiotropic mitochondria: the influence of mitochondria on neuronal development and disease. J Neurosci 39(42):8200\u20138208. https:\/\/doi.org\/10.1523\/jneurosci.1157-19.2019","journal-title":"J Neurosci"},{"issue":"44","key":"10947_CR2","doi-asserted-by":"publisher","first-page":"15716","DOI":"10.1523\/jneurosci.3159-11.2011","volume":"31","author":"AS Dickey","year":"2011","unstructured":"Dickey AS, Strack S (2011) PKA\/AKAP1 and PP2A\/B\u03922 regulate neuronal morphogenesis via DRP1 phosphorylation and mitochondrial bioenergetics. J Neurosci 31(44):15716\u201315726. https:\/\/doi.org\/10.1523\/jneurosci.3159-11.2011","journal-title":"J Neurosci"},{"issue":"2","key":"10947_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neuroscience.2006.01.034","volume":"141","author":"D Chang","year":"2006","unstructured":"Chang D, Reynolds I (2006) Differences in mitochondrial movement and morphology in young and mature primary cortical neurons in culture. Neuroscience 141(2):727\u2013736. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.01.034","journal-title":"Neuroscience"},{"issue":"6","key":"10947_CR4","doi-asserted-by":"publisher","first-page":"R393","DOI":"10.1152\/ajpregu.00584.2012","volume":"304","author":"M Picard","year":"2013","unstructured":"Picard M, Shirihai OS, Gentil BJ, Burelle Y (2013) Mitochondrial morphology transitions and functions: implications for retrograde signaling? AJP Regul Integr Comp Physiol 304(6):R393\u2013R406. https:\/\/doi.org\/10.1152\/ajpregu.00584.2012","journal-title":"AJP Regul Integr Comp Physiol"},{"issue":"4","key":"10947_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.cmet.2013.03.002","volume":"17","author":"M Liesa","year":"2013","unstructured":"Liesa M, Shirihai OS (2013) Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metabol 17(4):491\u2013506. https:\/\/doi.org\/10.1016\/j.cmet.2013.03.002","journal-title":"Cell Metabol"},{"key":"10947_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1042\/bse0470085","volume":"47","author":"I Scott","year":"2010","unstructured":"Scott I, Youle RJ (2010) Mitochondrial fission and fusion. Essays Biochem 47:85\u201398. https:\/\/doi.org\/10.1042\/bse0470085","journal-title":"Essays Biochem"},{"issue":"20","key":"10947_CR7","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1091\/mbc.e16-03-0193","volume":"27","author":"AL Hatch","year":"2016","unstructured":"Hatch AL, Ji W, Merrill RA, Strack S, Higgs HN (2016) Actin filaments as dynamic reservoirs for Drp1 recruitment. Mol Biol Cell 27(20):3109\u20133121. https:\/\/doi.org\/10.1091\/mbc.e16-03-0193","journal-title":"Mol Biol Cell"},{"key":"10947_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/293893","volume":"2013","author":"M Ranieri","year":"2013","unstructured":"Ranieri M, Brajkovic S, Riboldi G, Ronchi D, Rizzo F, Bresolin N, Corti S, Comi GP (2013) Mitochondrial fusion proteins and human diseases. Neurol Res Int 2013:1\u201311. https:\/\/doi.org\/10.1155\/2013\/293893","journal-title":"Neurol Res Int"},{"issue":"7","key":"10947_CR9","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cub.2005.02.064","volume":"15","author":"KJ De Vos","year":"2005","unstructured":"De Vos KJ, Allan VJ, Grierson AJ, Sheetz MP (2005) Mitochondrial function and actin regulate Dynamin-Related protein 1-Dependent mitochondrial fission. Curr Biol 15(7):678\u2013683. https:\/\/doi.org\/10.1016\/j.cub.2005.02.064","journal-title":"Curr Biol"},{"issue":"4","key":"10947_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.4103\/1673-5374.322429","volume":"17","author":"N Sun","year":"2021","unstructured":"Sun N, Ozgen S, Krigman J, Zhang R (2021) Significance of mitochondrial activity in neurogenesis and neurodegenerative diseases. Neural Regeneration Res 17(4):741. https:\/\/doi.org\/10.4103\/1673-5374.322429","journal-title":"Neural Regeneration Res"},{"issue":"4","key":"10947_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3390\/cells10040885","volume":"10","author":"P Portz","year":"2021","unstructured":"Portz P, Lee MK (2021) Changes in Drp1 function and mitochondrial morphology are associated with the \u03b1-Synuclein pathology in a Transgenic mouse model of parkinson\u2019s disease. Cells 10(4):885. https:\/\/doi.org\/10.3390\/cells10040885","journal-title":"Cells"},{"key":"10947_CR12","doi-asserted-by":"publisher","unstructured":"De La Cueva M, Antequera D, Ordo\u00f1ez-Gutierrez L, Wandosell F, Camins A, Carro E, Bartolome F (2022) Amyloid-\u03b2 impairs mitochondrial dynamics and autophagy in alzheimer\u2019s disease experimental models. Sci Rep 12(1). https:\/\/doi.org\/10.1038\/s41598-022-13683-3","DOI":"10.1038\/s41598-022-13683-3"},{"key":"10947_CR13","doi-asserted-by":"publisher","first-page":"104871","DOI":"10.1016\/j.neubiorev.2022.104871","volume":"142","author":"S Mani","year":"2022","unstructured":"Mani S, Jindal D, Chopra H, Jha SK, Singh SK, Ashraf GM, Kamal M, Iqbal D, Chellappan DK, Dey A, Dewanjee S, Singh KK, Ojha S, Singh I, Gautam RK, Jha NK (2022) ROCK2 inhibition: A futuristic approach for the management of alzheimer\u2019s disease. Neurosci Biobehavioral Reviews 142:104871. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104871","journal-title":"Neurosci Biobehavioral Reviews"},{"issue":"2","key":"10947_CR14","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.drudis.2019.11.017","volume":"25","author":"P Sharma","year":"2019","unstructured":"Sharma P, Roy K (2019) ROCK-2-selective targeting and its therapeutic outcomes. Drug Discovery Today 25(2):446\u2013455. https:\/\/doi.org\/10.1016\/j.drudis.2019.11.017","journal-title":"Drug Discovery Today"},{"issue":"5429","key":"10947_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1126\/science.285.5429.895","volume":"285","author":"M Maekawa","year":"1999","unstructured":"Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K, Narumiya S (1999) Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285(5429):895\u2013898. https:\/\/doi.org\/10.1126\/science.285.5429.895","journal-title":"Science"},{"issue":"2","key":"10947_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00018-009-0189-x","volume":"67","author":"C Hahmann","year":"2009","unstructured":"Hahmann C, Schroeter T (2009) Rho-kinase inhibitors as therapeutics: from Pan Inhibition to isoform selectivity. Cell Mol Life Sci 67(2):171\u2013177. https:\/\/doi.org\/10.1007\/s00018-009-0189-x","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"10947_CR17","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3390\/cells11091520","volume":"11","author":"SI Schmidt","year":"2022","unstructured":"Schmidt SI, Blaabjerg M, Freude K, Meyer M (2022) RHOA signaling in neurodegenerative diseases. Cells 11(9):1520. https:\/\/doi.org\/10.3390\/cells11091520","journal-title":"Cells"},{"issue":"7","key":"10947_CR18","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3390\/cells10071831","volume":"10","author":"N Mosaddeghzadeh","year":"2021","unstructured":"Mosaddeghzadeh N, Ahmadian MR (2021) The RHO family gtpases: mechanisms of regulation and signaling. Cells 10(7):1831. https:\/\/doi.org\/10.3390\/cells10071831","journal-title":"Cells"},{"issue":"2","key":"10947_CR19","doi-asserted-by":"publisher","first-page":"e29846","DOI":"10.4161\/sgtp.29846","volume":"5","author":"L Julian","year":"2014","unstructured":"Julian L, Olson MF (2014) Rho-associated coiled-coil containing kinases (ROCK). Small GTPases 5(2):e29846. https:\/\/doi.org\/10.4161\/sgtp.29846","journal-title":"Small GTPases"},{"key":"10947_CR20","doi-asserted-by":"publisher","first-page":"113481","DOI":"10.1016\/j.bbr.2021.113481","volume":"414","author":"R Cai","year":"2021","unstructured":"Cai R, Wang Y, Huang Z, Zou Q, Pu Y, Yu C, Cai Z (2021) Role of rhoa\/rock signaling in alzheimer\u2019s disease. Behav Brain Res 414:113481. https:\/\/doi.org\/10.1016\/j.bbr.2021.113481","journal-title":"Behav Brain Res"},{"issue":"17","key":"10947_CR21","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1128\/mcb.01735-06","volume":"27","author":"M Pelosi","year":"2007","unstructured":"Pelosi M, Marampon F, Zani BM, Prudente S, Perlas E, Caputo V, Cianetti L, Berno V, Narumiya S, Kang SW, Musar\u00f2 A, Rosenthal N (2007) ROCK2 and its alternatively spliced isoform ROCK2M positively control the maturation of the myogenic program. Mol Cell Biol 27(17):6163\u20136176. https:\/\/doi.org\/10.1128\/mcb.01735-06","journal-title":"Mol Cell Biol"},{"issue":"9","key":"10947_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/cm.20472","volume":"67","author":"M Amano","year":"2010","unstructured":"Amano M, Nakayama M, Kaibuchi K (2010) Rho-kinase\/ROCK: A key regulator of the cytoskeleton and cell Polarity. Cytoskeleton 67(9):545\u2013554. https:\/\/doi.org\/10.1002\/cm.20472","journal-title":"Cytoskeleton"},{"issue":"2","key":"10947_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/circresaha.115.306532","volume":"118","author":"H Shimokawa","year":"2016","unstructured":"Shimokawa H, Sunamura S, Satoh K (2016) RHOA\/Rho-Kinase in the cardiovascular system. Circul Res 118(2):352\u2013366. https:\/\/doi.org\/10.1161\/circresaha.115.306532","journal-title":"Circul Res"},{"issue":"2","key":"10947_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0014-5793(96)00811-3","volume":"392","author":"O Nakagawa","year":"1996","unstructured":"Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S (1996) ROCK-I and ROCK\u2010II, two isoforms of Rho\u2010associated coiled\u2010coil forming protein serine\/threonine kinase in mice. FEBS Lett 392(2):189\u2013193. https:\/\/doi.org\/10.1016\/0014-5793(96)00811-3","journal-title":"FEBS Lett"},{"key":"10947_CR25","doi-asserted-by":"publisher","unstructured":"Shi J, Wei L (2022) RHo kinases in embryonic development and stem cell research. Arch Immunol Ther Exp 70(1). https:\/\/doi.org\/10.1007\/s00005-022-00642-z","DOI":"10.1007\/s00005-022-00642-z"},{"issue":"4","key":"10947_CR26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/35070019","volume":"3","author":"M Sebbagh","year":"2001","unstructured":"Sebbagh M, Renvoiz\u00e9 C, Hamelin J, Rich\u00e9 N, Bertoglio J, Br\u00e9ard J (2001) Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol 3(4):346\u2013352. https:\/\/doi.org\/10.1038\/35070019","journal-title":"Nat Cell Biol"},{"key":"10947_CR27","doi-asserted-by":"publisher","unstructured":"Chang J, Xie M, Shah VR, Schneider MD, Entman ML, Wei L, Schwartz RJ (2006) Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis. Proceedings of the National Academy of Sciences, 103(39), 14495\u201314500. https:\/\/doi.org\/10.1073\/pnas.0601911103","DOI":"10.1073\/pnas.0601911103"},{"issue":"3","key":"10947_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1084\/jem.20031877","volume":"201","author":"M Sebbagh","year":"2005","unstructured":"Sebbagh M, Hamelin J, Bertoglio J, Solary E, Br\u00e9Ard J (2005) Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner. J Exp Med 201(3):465\u2013471. https:\/\/doi.org\/10.1084\/jem.20031877","journal-title":"J Exp Med"},{"issue":"38","key":"10947_CR29","doi-asserted-by":"publisher","first-page":"26263","DOI":"10.1074\/jbc.m803417200","volume":"283","author":"W Wen","year":"2008","unstructured":"Wen W, Liu W, Yan J, Zhang M (2008) Structure basis and unconventional lipid membrane binding properties of the PH-C1 tandem of RHO kinases. J Biol Chem 283(38):26263\u201326273. https:\/\/doi.org\/10.1074\/jbc.m803417200","journal-title":"J Biol Chem"},{"issue":"27","key":"10947_CR30","doi-asserted-by":"publisher","first-page":"21070","DOI":"10.1074\/jbc.m110.122549","volume":"285","author":"Z Chen","year":"2010","unstructured":"Chen Z, Medina F, Liu M, Thomas C, Sprang SR, Sternweis PC (2010) Activated RHOA binds to the pleckstrin homology (PH) domain of PDZ-RHOGEF, a potential site for autoregulation. J Biol Chem 285(27):21070\u201321081. https:\/\/doi.org\/10.1074\/jbc.m110.122549","journal-title":"J Biol Chem"},{"key":"10947_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2147\/jep.s259297","volume":"13","author":"G Al-Humimat","year":"2021","unstructured":"Al-Humimat G, Marashdeh I, Daradkeh D, Kooner K (2021) Investigational RHO kinase inhibitors for the treatment of glaucoma. J Experimental Pharmacol 13:197\u2013212. https:\/\/doi.org\/10.2147\/jep.s259297","journal-title":"J Experimental Pharmacol"},{"issue":"2","key":"10947_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00005-007-0009-7","volume":"55","author":"J Shi","year":"2007","unstructured":"Shi J, Wei L (2007) Rho kinase in the regulation of cell death and survival. Arch Immunol Ther Exp 55(2):61\u201375. https:\/\/doi.org\/10.1007\/s00005-007-0009-7","journal-title":"Arch Immunol Ther Exp"},{"issue":"15","key":"10947_CR33","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/1873-3468.14150","volume":"595","author":"M Hafeezunnisa","year":"2021","unstructured":"Hafeezunnisa M, Chhakchhuak PIR, Krishnakumar J, Sen R (2021) Rho-dependent transcription termination regulates the toxin\u2013antitoxin modules of cryptic prophages to silence their expression in Escherichia coli. FEBS Lett 595(15):2057\u20132067. https:\/\/doi.org\/10.1002\/1873-3468.14150","journal-title":"FEBS Lett"},{"key":"10947_CR34","doi-asserted-by":"publisher","unstructured":"Hartmann S, Ridley AJ, Lutz S (2015) The function of RHO-Associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease. Frontiers in Pharmacology, 6. https:\/\/doi.org\/10.3389\/fphar.2015.0027","DOI":"10.3389\/fphar.2015.0027"},{"issue":"2","key":"10947_CR35","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.1038\/cddis.2013.10","volume":"4","author":"J Shi","year":"2013","unstructured":"Shi J, Wu X, Surma M, Vemula S, Zhang L, Yang Y, Kapur R, Wei L (2013) Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment. Cell Death Dis 4(2):e483. https:\/\/doi.org\/10.1038\/cddis.2013.10","journal-title":"Cell Death Dis"},{"issue":"23","key":"10947_CR36","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1091\/mbc.e16-04-0253","volume":"27","author":"JX Chia","year":"2016","unstructured":"Chia JX, Efimova N, Svitkina TM (2016) Neurite outgrowth is driven by actin polymerization even in the presence of actin polymerization inhibitors. Mol Biol Cell 27(23):3695\u20133704. https:\/\/doi.org\/10.1091\/mbc.e16-04-0253","journal-title":"Mol Biol Cell"},{"issue":"9","key":"10947_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrm2957","volume":"11","author":"JT Parsons","year":"2010","unstructured":"Parsons JT, Horwitz AR, Schwartz MA (2010) Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol 11(9):633\u2013643. https:\/\/doi.org\/10.1038\/nrm2957","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10947_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.actbio.2019.02.015","volume":"88","author":"Y Peng","year":"2019","unstructured":"Peng Y, Chen Z, Chen Y, Li S, Jiang Y, Yang H, Wu C, You F, Zheng C, Zhu J, Tan Y, Qin X, Liu Y (2019) ROCK isoforms differentially modulate cancer cell motility by mechanosensing the substrate stiffness. Acta Biomater 88:86\u2013101. https:\/\/doi.org\/10.1016\/j.actbio.2019.02.015","journal-title":"Acta Biomater"},{"issue":"24","key":"10947_CR39","doi-asserted-by":"publisher","first-page":"8994","DOI":"10.1158\/0008-5472.can-04-2052","volume":"64","author":"DR Croft","year":"2004","unstructured":"Croft DR, Sahai E, Mavria G, Li S, Tsai J, Lee WMF, Marshall CJ, Olson MF (2004) Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res 64(24):8994\u20139001. https:\/\/doi.org\/10.1158\/0008-5472.can-04-2052","journal-title":"Cancer Res"},{"issue":"10","key":"10947_CR40","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/embor.2012.127","volume":"13","author":"N Rath","year":"2012","unstructured":"Rath N, Olson MF (2012) Rho-associated kinases in tumorigenesis: re\u2010considering ROCK Inhibition for cancer therapy. EMBO Rep 13(10):900\u2013908. https:\/\/doi.org\/10.1038\/embor.2012.127","journal-title":"EMBO Rep"},{"issue":"10","key":"10947_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0318-z","volume":"51","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Hu C, Huang J, Liu W, Lai W, Leng F, Tang Q, Liu Y, Wang Q, Zhou M, Sheng F, Li G, Zhang R (2019) ROCK1 induces dopaminergic nerve cell apoptosis via the activation of Drp1-mediated aberrant mitochondrial fission in parkinson\u2019s disease. Exp Mol Med 51(10):1\u201313. https:\/\/doi.org\/10.1038\/s12276-019-0318-z","journal-title":"Exp Mol Med"},{"key":"10947_CR42","doi-asserted-by":"publisher","unstructured":"Song C, Huang W, Zhang P, Shi J, Yu T, Wang J, Hu Y, Zhao L, Zhang R, Wang G, Zhang Y, Chen H, Wang H (2024) Critical role of ROCK1 in AD pathogenesis via controlling lysosomal biogenesis and acidification. Translational Neurodegeneration 13(1). https:\/\/doi.org\/10.1186\/s40035-024-00442-9","DOI":"10.1186\/s40035-024-00442-9"},{"key":"10947_CR43","doi-asserted-by":"publisher","unstructured":"Chen W, Zhao H, Li Y (2023) Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct Target Therapy 8(1). https:\/\/doi.org\/10.1038\/s41392-023-01547-9","DOI":"10.1038\/s41392-023-01547-9"},{"issue":"2","key":"10947_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1083\/jcb.200211046","volume":"160","author":"H Chen","year":"2003","unstructured":"Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC (2003) Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160(2):189\u2013200. https:\/\/doi.org\/10.1083\/jcb.200211046","journal-title":"J Cell Biol"},{"issue":"6","key":"10947_CR45","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1074\/jbc.m110.167155","volume":"286","author":"A Jahani-Asl","year":"2010","unstructured":"Jahani-Asl A, Pilon-Larose K, Xu W, MacLaurin JG, Park DS, McBride HM, Slack RS (2010) The mitochondrial inner membrane gtpase, optic atrophy 1 (Opa1), restores mitochondrial morphology and promotes neuronal survival following excitotoxicity. J Biol Chem 286(6):4772\u20134782. https:\/\/doi.org\/10.1074\/jbc.m110.167155","journal-title":"J Biol Chem"},{"issue":"46","key":"10947_CR46","doi-asserted-by":"publisher","first-page":"17262","DOI":"10.1074\/jbc.ra119.008202","volume":"294","author":"R Yu","year":"2019","unstructured":"Yu R, Liu T, Ning C, Tan F, Jin S, Lendahl U, Zhao J, Nist\u00e9r M (2019) The phosphorylation status of Ser-637 in dynamin-related protein 1 (Drp1) does not determine Drp1 recruitment to mitochondria. J Biol Chem 294(46):17262\u201317277. https:\/\/doi.org\/10.1074\/jbc.ra119.008202","journal-title":"J Biol Chem"},{"key":"10947_CR47","doi-asserted-by":"publisher","unstructured":"Gao Q, Tian R, Han H, Slone J, Wang C, Ke X, Zhang T, Li X, He Y, Liao P, Wang F, Chen Y, Fu S, Zhang K, Zeng F, Yang Y, Li Z, Tan J, Li J, Zhang Z (2022) PINK1-mediated Drp1S616 phosphorylation modulates synaptic development and plasticity via promoting mitochondrial fission. Signal Transduct Target Therapy 7(1). https:\/\/doi.org\/10.1038\/s41392-022-00933-z","DOI":"10.1038\/s41392-022-00933-z"},{"key":"10947_CR48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cellsig.2018.06.012","volume":"50","author":"CS Brand","year":"2018","unstructured":"Brand CS, Tan VP, Brown JH, Miyamoto S (2018) RhoA regulates Drp1 mediated mitochondrial fission through ROCK to protect cardiomyocytes. Cell Signal 50:48\u201357. https:\/\/doi.org\/10.1016\/j.cellsig.2018.06.012","journal-title":"Cell Signal"},{"issue":"2","key":"10947_CR49","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cmet.2012.01.009","volume":"15","author":"W Wang","year":"2012","unstructured":"Wang W, Wang Y, Long J, Wang J, Haudek SB, Overbeek P, Chang BH, Schumacker PT, Danesh FR (2012) Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metabol 15(2):186\u2013200. https:\/\/doi.org\/10.1016\/j.cmet.2012.01.009","journal-title":"Cell Metabol"},{"key":"10947_CR50","doi-asserted-by":"publisher","DOI":"10.1101\/366401","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Hu C, Huang J, Liu W, Lai W, Leng F, Tang Q, Liu Y, Wang Q, Zhou M, Sheng F, Li G, Zhang R (2018) ROCK1\/Drp1-mediated aberrant mitochondrial fission is crucial for dopaminergic nerve cell apoptosis. BioRxiv (Cold Spring Harbor Laboratory). https:\/\/doi.org\/10.1101\/366401","journal-title":"BioRxiv (Cold Spring Harbor Laboratory)"},{"issue":"48","key":"10947_CR51","doi-asserted-by":"publisher","first-page":"45208","DOI":"10.1021\/acsomega.3c06547","volume":"8","author":"A Adhikary","year":"2023","unstructured":"Adhikary A, Mukherjee A, Banerjee R, Nagotu S (2023) DRP1: at the crossroads of dysregulated mitochondrial dynamics and altered cell signaling in cancer cells. ACS Omega 8(48):45208\u201345223. https:\/\/doi.org\/10.1021\/acsomega.3c06547","journal-title":"ACS Omega"},{"issue":"6805","key":"10947_CR52","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/35037739","volume":"407","author":"J Yuan","year":"2000","unstructured":"Yuan J, Yankner BA (2000) Apoptosis in the nervous system. Nature 407(6805):802\u2013809. https:\/\/doi.org\/10.1038\/35037739","journal-title":"Nature"},{"key":"10947_CR53","doi-asserted-by":"publisher","unstructured":"Hu J, Zhang H, Li J, Jiang X, Zhang Y, Wu Q, Shen L, Shi J, Gao N (2020) ROCK1 activation-mediated mitochondrial translocation of Drp1 and Cofilin are required for arnidiol-induced mitochondrial fission and apoptosis. J Experimental Clin Cancer Res 39(1). https:\/\/doi.org\/10.1186\/s13046-020-01545-7","DOI":"10.1186\/s13046-020-01545-7"},{"key":"10947_CR54","doi-asserted-by":"publisher","unstructured":"Li G, Cheng Q, Liu L, Zhou T, Shan C, Hu X, Zhou J, Liu E, Li P, Gao N (2013) Mitochondrial translocation of Cofilin is required for allyl isothiocyanate-mediated cell death via ROCK1\/PTEN\/PI3K signaling pathway. Cell Communication Signal 11(1). https:\/\/doi.org\/10.1186\/1478-811x-11-50","DOI":"10.1186\/1478-811x-11-50"},{"issue":"4","key":"10947_CR55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/jipb.12445","volume":"58","author":"K Porter","year":"2015","unstructured":"Porter K, Day B (2015) From filaments to function: the role of the plant actin cytoskeleton in pathogen perception, signaling and immunity. J Integr Plant Biol 58(4):299\u2013311. https:\/\/doi.org\/10.1111\/jipb.12445","journal-title":"J Integr Plant Biol"},{"issue":"2","key":"10947_CR56","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/genes14020272","volume":"14","author":"G Guan","year":"2023","unstructured":"Guan G, Cannon RD, Coates DE, Mei L (2023) Effect of the Rho-Kinase\/ROCK signaling pathway on cytoskeleton components. Genes 14(2):272. https:\/\/doi.org\/10.3390\/genes14020272","journal-title":"Genes"},{"key":"10947_CR57","doi-asserted-by":"publisher","unstructured":"Weber AJ, Herskowitz JH (2021) Perspectives on ROCK2 as a therapeutic target for alzheimer\u2019s disease. Front Cell Neurosci 15. https:\/\/doi.org\/10.3389\/fncel.2021.636017","DOI":"10.3389\/fncel.2021.636017"},{"issue":"5","key":"10947_CR58","doi-asserted-by":"publisher","first-page":"e1225","DOI":"10.1038\/cddis.2014.191","volume":"5","author":"JC Koch","year":"2014","unstructured":"Koch JC, T\u00f6nges L, Barski E, Michel U, B\u00e4hr M, Lingor P (2014) ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS. Cell Death Dis 5(5):e1225. https:\/\/doi.org\/10.1038\/cddis.2014.191","journal-title":"Cell Death Dis"},{"issue":"1","key":"10947_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bpa.12545","volume":"28","author":"F Guo","year":"2017","unstructured":"Guo F, Liu X, Cai H, Le W (2017) Autophagy in neurodegenerative diseases: pathogenesis and therapy. Brain Pathol 28(1):3\u201313. https:\/\/doi.org\/10.1111\/bpa.12545","journal-title":"Brain Pathol"},{"key":"10947_CR60","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neuint.2017.08.004","volume":"117","author":"C Rodolfo","year":"2017","unstructured":"Rodolfo C, Campello S, Cecconi F (2017) Mitophagy in neurodegenerative diseases. Neurochem Int 117:156\u2013166. https:\/\/doi.org\/10.1016\/j.neuint.2017.08.004","journal-title":"Neurochem Int"},{"issue":"8","key":"10947_CR61","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41422-018-0056-0","volume":"28","author":"L Wang","year":"2018","unstructured":"Wang L, Cho Y, Tang Y, Wang J, Park J, Wu Y, Wang C, Tong Y, Chawla R, Zhang J, Shi Y, Deng S, Lu G, Wu Y, Tan HW, Pawijit P, Lim GG, Chan H, Zhang J, Shen H (2018) PTEN-L is a novel protein phosphatase for ubiquitin dephosphorylation to inhibit PINK1\u2013Parkin-mediated mitophagy. Cell Res 28(8):787\u2013802. https:\/\/doi.org\/10.1038\/s41422-018-0056-0","journal-title":"Cell Res"},{"key":"10947_CR62","doi-asserted-by":"publisher","first-page":"101817","DOI":"10.1016\/j.arr.2022.101817","volume":"84","author":"J Li","year":"2022","unstructured":"Li J, Yang D, Li Z, Zhao M, Wang D, Sun Z, Wen P, Dai Y, Gou F, Ji Y, Zhao D, Yang L (2022) PINK1\/Parkin-mediated mitophagy in neurodegenerative diseases. Ageing Res Rev 84:101817. https:\/\/doi.org\/10.1016\/j.arr.2022.101817","journal-title":"Ageing Res Rev"},{"key":"10947_CR63","doi-asserted-by":"publisher","unstructured":"Basak B, Holzbaur ELF (2025) Mitophagy in neurons: mechanisms regulating mitochondrial turnover and neuronal homeostasis. J Mol Biol 169161. https:\/\/doi.org\/10.1016\/j.jmb.2025.169161","DOI":"10.1016\/j.jmb.2025.169161"},{"issue":"23","key":"10947_CR64","doi-asserted-by":"publisher","first-page":"14788","DOI":"10.3390\/ijms232314788","volume":"23","author":"NCDS Moreira","year":"2022","unstructured":"Moreira NCDS, Tamarozzi ER, De Freitas Lima JEB, De Oliveira Piassi L, Carvalho I, Passos GA, Sakamoto-Hojo ET (2022) Novel dual ACHE and ROCK2 inhibitor induces neurogenesis via PTEN\/AKT pathway in alzheimer\u2019s disease model. Int J Mol Sci 23(23):14788. https:\/\/doi.org\/10.3390\/ijms232314788","journal-title":"Int J Mol Sci"},{"key":"10947_CR65","doi-asserted-by":"publisher","unstructured":"Moskal N, Riccio V, Bashkurov M, Taddese R, Datti A, Lewis PN, McQuibban GA (2020) ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway. Nat Commun 11(1). https:\/\/doi.org\/10.1038\/s41467-019-13781-3","DOI":"10.1038\/s41467-019-13781-3"},{"key":"10947_CR66","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16973","author":"H Quadir","year":"2021","unstructured":"Quadir H, Hakobyan K, Gaddam M, Ojinnaka U, Ahmed Z, Kannan A, Mostafa JA (2021) Role of RHO-Associated protein kinase Inhibition as therapeutic strategy for parkinson\u2019s disease: dopaminergic survival and enhanced mitophagy. Cureus. https:\/\/doi.org\/10.7759\/cureus.16973","journal-title":"Cureus"},{"key":"10947_CR67","doi-asserted-by":"publisher","first-page":"106835","DOI":"10.1016\/j.phrs.2023.106835","volume":"194","author":"Y Dong","year":"2023","unstructured":"Dong Y, Zhuang X, Wang Y, Tan J, Feng D, Li M, Zhong Q, Song Z, Shen H, Fang EF, Lu J (2023) Chemical mitophagy modulators: drug development strategies and novel regulatory mechanisms. Pharmacol Res 194:106835. https:\/\/doi.org\/10.1016\/j.phrs.2023.106835","journal-title":"Pharmacol Res"},{"issue":"12","key":"10947_CR68","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.devcel.2021.04.021","volume":"56","author":"L Chen","year":"2021","unstructured":"Chen L, Lin C, Lin L, Hsu J, Wu Y, Pan C (2021) Neuronal mitochondrial dynamics coordinate systemic mitochondrial morphology and stress response to confer pathogen resistance in C. elegans. Dev Cell 56(12):1770\u20131785e12. https:\/\/doi.org\/10.1016\/j.devcel.2021.04.021","journal-title":"Dev Cell"},{"key":"10947_CR69","doi-asserted-by":"publisher","unstructured":"Sayehmiri F, Motamedi F, Batool Z, Naderi N, Shaerzadeh F, Zoghi A, Rezaei O, Khodagholi F, Pourbadie HG (2024) Mitochondrial plasticity and synaptic plasticity crosstalk; in health and alzheimer\u2019s disease. CNS Neurosci Ther 30(8). https:\/\/doi.org\/10.1111\/cns.14897","DOI":"10.1111\/cns.14897"},{"issue":"1","key":"10947_CR70","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neuropharm.2008.07.031","volume":"56","author":"Z Zhou","year":"2008","unstructured":"Zhou Z, Meng Y, Asrar S, Todorovski Z, Jia Z (2008) A critical role of Rho-kinase ROCK2 in the regulation of spine and synaptic function. Neuropharmacology 56(1):81\u201389. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.07.031","journal-title":"Neuropharmacology"},{"issue":"6","key":"10947_CR71","doi-asserted-by":"publisher","first-page":"e11236","DOI":"10.1371\/journal.pone.0011236","volume":"5","author":"KT Ota","year":"2010","unstructured":"Ota KT, Monsey MS, Wu MS, Schafe GE (2010) Synaptic plasticity and NO-CGMP-PKG signaling regulate pre- and postsynaptic alterations at rat lateral amygdala synapses following fear conditioning. PLoS ONE 5(6):e11236. https:\/\/doi.org\/10.1371\/journal.pone.0011236","journal-title":"PLoS ONE"},{"issue":"4","key":"10947_CR72","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s12264-019-00351-2","volume":"35","author":"J Yan","year":"2019","unstructured":"Yan J, Pan Y, Zheng X, Zhu C, Zhang Y, Shi G, Yao L, Chen Y, Xu N (2019) Comparative study of ROCK1 and ROCK2 in hippocampal spine formation and synaptic function. Neurosci Bull 35(4):649\u2013660. https:\/\/doi.org\/10.1007\/s12264-019-00351-2","journal-title":"Neurosci Bull"},{"key":"10947_CR73","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-981-97-9959-6_4","volume-title":"Biomaterials and neurodegenerative disorders","author":"K Ramakrishna","year":"2025","unstructured":"Ramakrishna K, Viswanadh MK, Dumala N, Chakravarth G, Venkateswarlu K, Gutti G, Yadagiri G, Duguluri S, Rai SN (2025) Advanced biomaterials in neuroprotection: innovations and clinical applications. Biomaterials and neurodegenerative disorders. Springer, Singapore, pp 69\u201392. https:\/\/doi.org\/10.1007\/978-981-97-9959-6_4"},{"issue":"12","key":"10947_CR74","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.3390\/antiox11122345","volume":"11","author":"V Ngo","year":"2022","unstructured":"Ngo V, Duennwald ML (2022) NRF2 and oxidative stress: A general overview of mechanisms and implications in human disease. Antioxidants 11(12):2345. https:\/\/doi.org\/10.3390\/antiox11122345","journal-title":"Antioxidants"},{"key":"10947_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2017.03.025","volume":"806","author":"J Chen","year":"2017","unstructured":"Chen J, Yin W, Tu Y, Wang S, Yang X, Chen Q, Zhang X, Han Y, Pi R (2017) L-F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: involvement of NF-\u03baB Inhibition and Nrf2 pathway activation. Eur J Pharmacol 806:1\u20139. https:\/\/doi.org\/10.1016\/j.ejphar.2017.03.025","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10947_CR76","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/cns.13116","volume":"25","author":"Y Wang","year":"2019","unstructured":"Wang Y, Xu E, Musich PR, Lin F (2019) Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neurosci Ther 25(7):816\u2013824. https:\/\/doi.org\/10.1111\/cns.13116","journal-title":"CNS Neurosci Ther"},{"issue":"10","key":"10947_CR77","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1038\/s41401-022-00879-6","volume":"43","author":"M Lin","year":"2022","unstructured":"Lin M, Liu N, Qin Z, Wang Y (2022) Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases. Acta Pharmacol Sin 43(10):2439\u20132447. https:\/\/doi.org\/10.1038\/s41401-022-00879-6","journal-title":"Acta Pharmacol Sin"},{"issue":"12","key":"10947_CR78","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1212\/wnl.0000000000207779","volume":"101","author":"E Benarroch","year":"2023","unstructured":"Benarroch E (2023) What is the role of the RhO-ROCK pathway in neurologic disorders? Neurology 101(12):536\u2013543. https:\/\/doi.org\/10.1212\/wnl.0000000000207779","journal-title":"Neurology"},{"key":"10947_CR79","doi-asserted-by":"publisher","first-page":"115141","DOI":"10.1016\/j.biopha.2023.115141","volume":"165","author":"W Lu","year":"2023","unstructured":"Lu W, Chen Z, Wen J (2023) The role of rhoa\/rock pathway in the ischemic stroke-induced neuroinflammation. Biomed Pharmacother 165:115141. https:\/\/doi.org\/10.1016\/j.biopha.2023.115141","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10947_CR80","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physiolgenomics.00062.2002","volume":"11","author":"DM Tham","year":"2002","unstructured":"Tham DM, Martin-McNulty B, Wang Y, Wilson DW, Vergona R, Sullivan ME, Dole W, Rutledge JC (2002) Angiotensin II is associated with activation of NF-\u03baB-mediated genes and downregulation of PPARs. Physiol Genom 11(1):21\u201330. https:\/\/doi.org\/10.1152\/physiolgenomics.00062.2002","journal-title":"Physiol Genom"},{"issue":"10","key":"10947_CR81","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3390\/cells12101367","volume":"12","author":"EJ Glotfelty","year":"2023","unstructured":"Glotfelty EJ, Tovar-Y-Romo LB, Hsueh S, Tweedie D, Li Y, Harvey BK, Hoffer BJ, Karlsson TE, Olson L, Greig NH (2023) The RHOA-ROCK1\/ROCK2 pathway exacerbates inflammatory signaling in immortalized and primary microglia. Cells 12(10):1367. https:\/\/doi.org\/10.3390\/cells12101367","journal-title":"Cells"},{"issue":"6","key":"10947_CR82","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.cmet.2013.11.005","volume":"18","author":"E Motori","year":"2013","unstructured":"Motori E, Puyal J, Toni N, Ghanem A, Angeloni C, Malaguti M, Cantelli-Forti G, Berninger B, Conzelmann K, G\u00f6tz M, Winklhofer KF, Hrelia S, Bergami M (2013) Inflammation-Induced alteration of astrocyte mitochondrial dynamics requires autophagy for mitochondrial network maintenance. Cell Metabol 18(6):844\u2013859. https:\/\/doi.org\/10.1016\/j.cmet.2013.11.005","journal-title":"Cell Metabol"},{"key":"10947_CR83","doi-asserted-by":"publisher","first-page":"106561","DOI":"10.1016\/j.nbd.2024.106561","volume":"198","author":"P Cai","year":"2024","unstructured":"Cai P, Li W, Xu Y, Wang H (2024) Drp1 and neuroinflammation: Deciphering the interplay between mitochondrial dynamics imbalance and inflammation in neurodegenerative diseases. Neurobiol Dis 198:106561. https:\/\/doi.org\/10.1016\/j.nbd.2024.106561","journal-title":"Neurobiol Dis"},{"key":"10947_CR84","doi-asserted-by":"publisher","unstructured":"Rahman MH, Suk K (2020) Mitochondrial dynamics and bioenergetic alteration during inflammatory activation of astrocytes. Front Aging Neurosci 12. https:\/\/doi.org\/10.3389\/fnagi.2020.614410","DOI":"10.3389\/fnagi.2020.614410"},{"key":"10947_CR85","doi-asserted-by":"publisher","unstructured":"Zhang X, Tang L, Yang J, Meng L, Chen J, Zhou L, Wang J, Xiong M, Zhang Z (2023) Soluble TREM2 ameliorates Tau phosphorylation and cognitive deficits through activating transgelin-2 in alzheimer\u2019s disease. Nat Commun 14(1). https:\/\/doi.org\/10.1038\/s41467-023-42505-x","DOI":"10.1038\/s41467-023-42505-x"},{"issue":"4","key":"10947_CR86","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Silverberg N (2018) NIA-AA research framework: toward a biological definition of alzheimer\u2019s disease. Alzheimer S Dement 14(4):535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimer S Dement"},{"key":"10947_CR87","doi-asserted-by":"publisher","unstructured":"Azargoonjahromi A (2024) The duality of amyloid-\u03b2: its role in normal and alzheimer\u2019s disease States. Mol Brain 17(1). https:\/\/doi.org\/10.1186\/s13041-024-01118-1","DOI":"10.1186\/s13041-024-01118-1"},{"issue":"6","key":"10947_CR88","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s11011-019-00487-0","volume":"34","author":"Y Gao","year":"2019","unstructured":"Gao Y, Yan Y, Fang Q, Zhang N, Kumar G, Zhang J, Song L, Yu J, Zhao L, Zhang H, Ma C (2019) The Rho kinase inhibitor fasudil attenuates A\u03b21\u201342-induced apoptosis via the ASK1\/JNK signal pathway in primary cultures of hippocampal neurons. Metab Brain Dis 34(6):1787\u20131801. https:\/\/doi.org\/10.1007\/s11011-019-00487-0","journal-title":"Metab Brain Dis"},{"issue":"4","key":"10947_CR89","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/jnc.13688","volume":"138","author":"BW Henderson","year":"2016","unstructured":"Henderson BW, Gentry EG, Rush T, Troncoso JC, Thambisetty M, Montine TJ, Herskowitz JH (2016) Rho-associated protein kinase 1 (ROCK1) is increased in alzheimer\u2019s disease and ROCK1 depletion reduces amyloid\u2010\u03b2 levels in brain. J Neurochem 138(4):525\u2013531. https:\/\/doi.org\/10.1111\/jnc.13688","journal-title":"J Neurochem"},{"key":"10947_CR90","doi-asserted-by":"publisher","unstructured":"Ye Q, Li X, Gao W, Gao J, Zheng L, Zhang M, Yang F, Li H (2024) Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases. Front NeuroSci 18. https:\/\/doi.org\/10.3389\/fnins.2024.1481983","DOI":"10.3389\/fnins.2024.1481983"},{"issue":"20","key":"10947_CR91","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1523\/jneurosci.2385-16.2017","volume":"37","author":"SH Baek","year":"2017","unstructured":"Baek SH, Park SJ, Jeong JI, Kim SH, Han J, Kyung JW, Baik S, Choi Y, Choi BY, Park JS, Bahn G, Shin JH, Jo DS, Lee J, Jang C, Arumugam TV, Kim J, Han J, Koh J, Jo D (2017) Inhibition of DRP1 ameliorates synaptic depression, A\u0392 deposition, and cognitive impairment in an alzheimer\u2019s disease model. J Neurosci 37(20):5099\u20135110. https:\/\/doi.org\/10.1523\/jneurosci.2385-16.2017","journal-title":"J Neurosci"},{"issue":"4","key":"10947_CR92","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s12276-022-00754-8","volume":"54","author":"J Hur","year":"2022","unstructured":"Hur J (2022) \u03b3-Secretase in alzheimer\u2019s disease. Exp Mol Med 54(4):433\u2013446. https:\/\/doi.org\/10.1038\/s12276-022-00754-8","journal-title":"Exp Mol Med"},{"issue":"9","key":"10947_CR93","doi-asserted-by":"publisher","first-page":"5516","DOI":"10.1111\/ejn.15611","volume":"56","author":"A Bera","year":"2022","unstructured":"Bera A, Lavanya G, Reshmi R, Dev K, Kumar R (2022) Mechanistic and therapeutic role of Drp1 in the pathogenesis of alzheimer\u2019s disease. Eur J Neurosci 56(9):5516\u20135531. https:\/\/doi.org\/10.1111\/ejn.15611","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10947_CR94","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3233\/jad-2010-100816","volume":"22","author":"C Zhang","year":"2010","unstructured":"Zhang C, Browne A, DiVito JR, Stevenson JA, Romano D, Dong Y, Xie Z, Tanzi RE (2010) Amyloid-\u03b2 production via cleavage of Amyloid-\u03b2 protein precursor is modulated by cell density. J Alzheimer S Disease 22(2):683\u2013694. https:\/\/doi.org\/10.3233\/jad-2010-100816","journal-title":"J Alzheimer S Disease"},{"key":"10947_CR95","doi-asserted-by":"publisher","unstructured":"Hu Y, Zou Y, Huang Y, Zhang Y, Lourenco GF, Chen S, Halliday GM, Wang G, Ren R (2016) ROCK1 is associated with alzheimer\u2019s Disease-Specific plaques, as well as enhances autophagosome formation but not autophagic A\u03b2 clearance. Front Cell Neurosci 10. https:\/\/doi.org\/10.3389\/fncel.2016.00253","DOI":"10.3389\/fncel.2016.00253"},{"issue":"5648","key":"10947_CR96","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1126\/science.1090154","volume":"302","author":"Y Zhou","year":"2003","unstructured":"Zhou Y, Su Y, Li B, Liu F, Ryder JW, Wu X, Gonzalez-DeWhitt PA, Gelfanova V, Hale JE, May PC, Paul SM, Ni B (2003) Nonsteroidal Anti-Inflammatory drugs can lower amyloidogenic ASS 42 by inhibiting RHO. Science 302(5648):1215\u20131217. https:\/\/doi.org\/10.1126\/science.1090154","journal-title":"Science"},{"issue":"6","key":"10947_CR97","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41380-023-02113-z","volume":"28","author":"N Basheer","year":"2023","unstructured":"Basheer N, Smolek T, Hassan I, Liu F, Iqbal K, Zilka N, Novak P (2023) Does modulation of Tau hyperphosphorylation represent a reasonable therapeutic strategy for alzheimer\u2019s disease? From preclinical studies to the clinical trials. Mol Psychiatry 28(6):2197\u20132214. https:\/\/doi.org\/10.1038\/s41380-023-02113-z","journal-title":"Mol Psychiatry"},{"key":"10947_CR98","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2019.12.009","volume":"89","author":"T Hamano","year":"2019","unstructured":"Hamano T, Shirafuji N, Yen S, Yoshida H, Kanaan NM, Hayashi K, Ikawa M, Yamamura O, Fujita Y, Kuriyama M, Nakamoto Y (2019) Rho-kinase ROCK inhibitors reduce oligomeric Tau protein. Neurobiol Aging 89:41\u201354. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.12.009","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10947_CR99","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1523\/jneurosci.2336-15.2016","volume":"36","author":"EG Gentry","year":"2016","unstructured":"Gentry EG, Henderson BW, Arrant AE, Gearing M, Feng Y, Riddle NC, Herskowitz JH (2016) RHO kinase Inhibition as a therapeutic for progressive supranuclear palsy and corticobasal degeneration. J Neurosci 36(4):1316\u20131323. https:\/\/doi.org\/10.1523\/jneurosci.2336-15.2016","journal-title":"J Neurosci"},{"key":"10947_CR100","doi-asserted-by":"publisher","unstructured":"Weber AJ, Adamson AB, Greathouse KM, Andrade JP, Freeman CD, Seo JV, Rae RJ, Walker CK, Herskowitz JH (2021) Conditional deletion of ROCK2 induces anxiety-like behaviors and alters dendritic spine density and morphology on CA1 pyramidal neurons. Mol Brain 14(1). https:\/\/doi.org\/10.1186\/s13041-021-00878-4","DOI":"10.1186\/s13041-021-00878-4"},{"issue":"3","key":"10947_CR101","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jalz.2017.09.008","volume":"14","author":"KJ Sellers","year":"2017","unstructured":"Sellers KJ, Elliott C, Jackson J, Ghosh A, Ribe E, Rojo AI, Jarosz-Griffiths HH, Watson IA, Xia W, Semenov M, Morin P, Hooper NM, Porter R, Preston J, Al\u2010Shawi R, Baillie G, Lovestone S, Cuadrado A, Harte M, Killick R (2017) Amyloid \u03b2 synaptotoxicity is Wnt\u2010PCP dependent and blocked by fasudil. Alzheimer S Dement 14(3):306\u2013317. https:\/\/doi.org\/10.1016\/j.jalz.2017.09.008","journal-title":"Alzheimer S Dement"},{"issue":"22","key":"10947_CR102","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1016\/j.cub.2019.09.040","volume":"29","author":"S Dupraz","year":"2019","unstructured":"Dupraz S, Hilton BJ, Husch A, Santos TE, Coles CH, Stern S, Brakebusch C, Bradke F (2019) RHOA controls axon extension independent of specification in the developing brain. Curr Biol 29(22):3874\u20133886e9. https:\/\/doi.org\/10.1016\/j.cub.2019.09.040","journal-title":"Curr Biol"},{"key":"10947_CR103","doi-asserted-by":"publisher","unstructured":"Ahmad F, Rankawat S, Pathak U (2022) ROCKs as a potential drug target to combat Alzheimer\u2019s disease. In Elsevier eBooks (pp. 409\u2013433). https:\/\/doi.org\/10.1016\/b978-0-323-91287-7.00012-0","DOI":"10.1016\/b978-0-323-91287-7.00012-0"},{"issue":"1","key":"10947_CR104","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"18","author":"H Ye","year":"2022","unstructured":"Ye H, Robak LA, Yu M, Cykowski M, Shulman JM (2022) Genetics and pathogenesis of parkinson\u2019s syndrome. Annual Rev Pathol Mech Disease 18(1):95\u2013121. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-034145","journal-title":"Annual Rev Pathol Mech Disease"},{"issue":"s1","key":"10947_CR105","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/jpd-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Parkinson S Disease 8(s1):S3\u2013S8. https:\/\/doi.org\/10.3233\/jpd-181474","journal-title":"J Parkinson S Disease"},{"issue":"7","key":"10947_CR106","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1086\/644537","volume":"200","author":"DM Morens","year":"2009","unstructured":"Morens DM, Folkers GK, Fauci AS (2009) What is a pandemic? J Infect Dis 200(7):1018\u20131021. https:\/\/doi.org\/10.1086\/644537","journal-title":"J Infect Dis"},{"issue":"1","key":"10947_CR107","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2017","unstructured":"Dorsey ER, Bloem BR (2017) The Parkinson Pandemic\u2014A call to action. JAMA Neurol 75(1):9. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3299","journal-title":"JAMA Neurol"},{"issue":"11","key":"10947_CR108","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1093\/brain\/aws254","volume":"135","author":"L Tonges","year":"2012","unstructured":"Tonges L, Frank T, Tatenhorst L, Saal KA, Koch JC, Szego EM, Bahr M, Weishaupt JH, Lingor P (2012) Inhibition of Rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of parkinson\u2019s disease. Brain 135(11):3355\u20133370. https:\/\/doi.org\/10.1093\/brain\/aws254","journal-title":"Brain"},{"issue":"6","key":"10947_CR109","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.3390\/ijms24065785","volume":"24","author":"M Zerihun","year":"2023","unstructured":"Zerihun M, Sukumaran S, Qvit N (2023) The DRP1-Mediated mitochondrial fission protein interactome as an emerging core player in mitochondrial dynamics and cardiovascular disease therapy. Int J Mol Sci 24(6):5785. https:\/\/doi.org\/10.3390\/ijms24065785","journal-title":"Int J Mol Sci"},{"key":"10947_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.05.021","volume":"85","author":"A Borrajo","year":"2014","unstructured":"Borrajo A, Rodriguez-Perez AI, Villar-Cheda B, Guerra MJ, Labandeira-Garcia JL (2014) Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death. Neuropharmacology 85:1\u20138. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.05.021","journal-title":"Neuropharmacology"},{"issue":"13","key":"10947_CR111","doi-asserted-by":"publisher","first-page":"11649","DOI":"10.1074\/jbc.m110.144238","volume":"286","author":"H Wang","year":"2011","unstructured":"Wang H, Song P, Du L, Tian W, Yue W, Liu M, Li D, Wang B, Zhu Y, Cao C, Zhou J, Chen Q (2011) Parkin ubiquitinates DRP1 for proteasome-dependent degradation. J Biol Chem 286(13):11649\u201311658. https:\/\/doi.org\/10.1074\/jbc.m110.144238","journal-title":"J Biol Chem"},{"issue":"7","key":"10947_CR112","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1007\/s12035-016-0027-8","volume":"54","author":"Y Li","year":"2016","unstructured":"Li Y, Yu J, Xi J, Yu W, Liu J, Wang Q, Song L, Feng L, Yan Y, Zhang G, Xiao B, Ma C (2016) Fasudil enhances therapeutic efficacy of neural stem cells in the mouse model of MPTP-Induced parkinson\u2019s disease. Mol Neurobiol 54(7):5400\u20135413. https:\/\/doi.org\/10.1007\/s12035-016-0027-8","journal-title":"Mol Neurobiol"},{"key":"10947_CR113","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.brainres.2015.12.002","volume":"1632","author":"F Liu","year":"2015","unstructured":"Liu F, Yang Y, Wu J, Li S, Tang Y, Zhao J, Liu Z, Xiao B, Zuo J, Liu W, Wang J (2015) Fasudil, a Rho kinase inhibitor, promotes the autophagic degradation of A53T \u03b1-synuclein by activating the JNK 1\/Bcl-2\/beclin 1 pathway. Brain Res 1632:9\u201318. https:\/\/doi.org\/10.1016\/j.brainres.2015.12.002","journal-title":"Brain Res"},{"issue":"1","key":"10947_CR114","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/bpa.12346","volume":"27","author":"K Saal","year":"2016","unstructured":"Saal K, Galter D, Roeber S, B\u00e4hr M, T\u00f6nges L, Lingor P (2016) Altered expression of growth associated Protein-43 and Rho kinase in human patients with parkinson\u2019s disease. Brain Pathol 27(1):13\u201325. https:\/\/doi.org\/10.1111\/bpa.12346","journal-title":"Brain Pathol"},{"issue":"7","key":"10947_CR115","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10654-018-0392-x","volume":"33","author":"B Marin","year":"2018","unstructured":"Marin B, Fontana A, Arcuti S, Copetti M, Boum\u00e9diene F, Couratier P, Beghi E, Preux PM, Logroscino G (2018) Age-specific ALS incidence: a dose\u2013response meta-analysis. Eur J Epidemiol 33(7):621\u2013634. https:\/\/doi.org\/10.1007\/s10654-018-0392-x","journal-title":"Eur J Epidemiol"},{"key":"10947_CR116","doi-asserted-by":"publisher","unstructured":"Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA (2019) ALS genetics, mechanisms, and therapeutics: where are we now? Front NeuroSci 13. https:\/\/doi.org\/10.3389\/fnins.2019.01310","DOI":"10.3389\/fnins.2019.01310"},{"key":"10947_CR117","doi-asserted-by":"publisher","first-page":"132933","DOI":"10.1016\/j.neulet.2017.06.052","volume":"710","author":"EF Smith","year":"2017","unstructured":"Smith EF, Shaw PJ, De Vos KJ (2017) The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett 710:132933. https:\/\/doi.org\/10.1016\/j.neulet.2017.06.052","journal-title":"Neurosci Lett"},{"key":"10947_CR118","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2018.07.005","volume":"122","author":"CS Evans","year":"2018","unstructured":"Evans CS, Holzbaur EL (2018) Autophagy and mitophagy in ALS. Neurobiol Dis 122:35\u201340. https:\/\/doi.org\/10.1016\/j.nbd.2018.07.005","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10947_CR119","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbadis.2013.10.013","volume":"1842","author":"A Conti","year":"2013","unstructured":"Conti A, Riva N, Pesca M, Iannaccone S, Cannistraci CV, Corbo M, Previtali SC, Quattrini A, Alessio M (2013) Increased expression of myosin binding protein H in the skeletal muscle of amyotrophic lateral sclerosis patients. Biochim Et Biophys Acta (BBA) - Mol Basis Disease 1842(1):99\u2013106. https:\/\/doi.org\/10.1016\/j.bbadis.2013.10.013","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Basis Disease"},{"issue":"5","key":"10947_CR120","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2990.2007.00850.x","volume":"33","author":"M Dewil","year":"2007","unstructured":"Dewil M, Lambrechts D, Sciot R, Shaw PJ, Ince PG, Robberecht W, Van Den Bosch L (2007) Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 33(5):499\u2013509. https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00850.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"10947_CR121","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/glia.22601","volume":"62","author":"L T\u00f6nges","year":"2013","unstructured":"T\u00f6nges L, G\u00fcnther R, Suhr M, Jansen J, Balck A, Saal K, Barski E, Nientied T, G\u00f6tz AA, Koch J, Mueller BK, Weishaupt JH, Sereda MW, Hanisch U, B\u00e4hr M, Lingor P (2013) Rho kinase Inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis. Glia 62(2):217\u2013232. https:\/\/doi.org\/10.1002\/glia.22601","journal-title":"Glia"},{"issue":"2","key":"10947_CR122","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/bph.12277","volume":"170","author":"M Takata","year":"2013","unstructured":"Takata M, Tanaka H, Kimura M, Nagahara Y, Tanaka K, Kawasaki K, Seto M, Tsuruma K, Shimazawa M, Hara H (2013) Fasudil, a Rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis. Br J Pharmacol 170(2):341\u2013351. https:\/\/doi.org\/10.1111\/bph.12277","journal-title":"Br J Pharmacol"},{"issue":"14","key":"10947_CR123","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1002\/cne.24679","volume":"527","author":"AR Joshi","year":"2019","unstructured":"Joshi AR, Muke I, Bobylev I, Lehmann HC (2019) ROCK Inhibition improves axonal regeneration in a preclinical model of amyotrophic lateral sclerosis. J Comp Neurol 527(14):2334\u20132340. https:\/\/doi.org\/10.1002\/cne.24679","journal-title":"J Comp Neurol"},{"key":"10947_CR124","doi-asserted-by":"publisher","unstructured":"G\u00fcnther R, Balck A, Koch JC, Nientiedt T, Sereda M, B\u00e4hr M, Lingor P, T\u00f6nges L (2017) Rho Kinase Inhibition with Fasudil in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis\u2014Symptomatic Treatment Potential after Disease Onset. Frontiers in Pharmacology, 8. https:\/\/doi.org\/10.3389\/fphar.2017.00017","DOI":"10.3389\/fphar.2017.00017"},{"key":"10947_CR125","doi-asserted-by":"publisher","first-page":"104743","DOI":"10.1016\/j.nbd.2020.104743","volume":"136","author":"TR Stankiewicz","year":"2020","unstructured":"Stankiewicz TR, Pena C, Bouchard RJ, Linseman DA (2020) Dysregulation of Rac or Rho elicits death of motor neurons and activation of these GTPases is altered in the G93A mutant hSOD1 mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 136:104743. https:\/\/doi.org\/10.1016\/j.nbd.2020.104743","journal-title":"Neurobiol Dis"},{"key":"10947_CR126","doi-asserted-by":"publisher","unstructured":"Lingor P, Weber M, Camu W, Friede T, Hilgers R, Leha A, Neuwirth C, G\u00fcnther R, Benatar M, Kuzma-Kozakiewicz M, Bidner H, Blankenstein C, Frontini R, Ludolph A, Koch JC (2019) ROCK-ALS: Protocol for a randomized, Placebo-Controlled, Double-Blind Phase IIA trial of safety, tolerability and efficacy of the RHO Kinase (ROCK) inhibitor Fasudil in amyotrophic lateral sclerosis. Frontiers in Neurology, 10. https:\/\/doi.org\/10.3389\/fneur.2019.00293","DOI":"10.3389\/fneur.2019.00293"},{"issue":"1","key":"10947_CR127","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2017","unstructured":"McColgan P, Tabrizi SJ (2017) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334. https:\/\/doi.org\/10.1111\/ene.13413","journal-title":"Eur J Neurol"},{"issue":"12","key":"10947_CR128","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.febslet.2008.04.009","volume":"582","author":"J Shao","year":"2008","unstructured":"Shao J, Welch WJ, Diamond MI (2008) ROCK and PRK-2 mediate the inhibitory effect of Y\u201027632 on polyglutamine aggregation. FEBS Lett 582(12):1637\u20131642. https:\/\/doi.org\/10.1016\/j.febslet.2008.04.009","journal-title":"FEBS Lett"},{"issue":"4","key":"10947_CR129","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1007\/s12035-015-9147-9","volume":"53","author":"KL Narayanan","year":"2015","unstructured":"Narayanan KL, Chopra V, Rosas HD, Malarick K, Hersch S (2015) RHO kinase pathway alterations in the brain and leukocytes in huntington\u2019s disease. Mol Neurobiol 53(4):2132\u20132140. https:\/\/doi.org\/10.1007\/s12035-015-9147-9","journal-title":"Mol Neurobiol"},{"key":"10947_CR130","doi-asserted-by":"publisher","unstructured":"Charvin D, Vanhoutte P, Pag\u00e8s C, Borelli E, Caboche J (2005) Unraveling a role for dopamine in Huntington\u2019s disease: The dual role of reactive oxygen species and D2 receptor stimulation. Proceedings of the National Academy of Sciences, 102(34), 12218\u201312223. https:\/\/doi.org\/10.1073\/pnas.0502698102","DOI":"10.1073\/pnas.0502698102"},{"issue":"12","key":"10947_CR131","doi-asserted-by":"publisher","first-page":"e8287","DOI":"10.1371\/journal.pone.0008287","volume":"4","author":"C Deyts","year":"2009","unstructured":"Deyts C, Galan-Rodriguez B, Martin E, Bouveyron N, Roze E, Charvin D, Caboche J, B\u00e9tuing S (2009) Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-Induced mouse striatal neuron dysfunctions via RHO\/ROCK-II activation. PLoS ONE 4(12):e8287. https:\/\/doi.org\/10.1371\/journal.pone.0008287","journal-title":"PLoS ONE"},{"issue":"1","key":"10947_CR132","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ejn.13132","volume":"43","author":"Q He","year":"2015","unstructured":"He Q, Li Y, Guo S, Wang Y, Lin W, Zhang Q, Wang J, Ma C, Xiao B (2015) Inhibition of Rho-kinase by fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide\u2010mediated parkinson\u2019s model. Eur J Neurosci 43(1):41\u201352. https:\/\/doi.org\/10.1111\/ejn.13132","journal-title":"Eur J Neurosci"},{"issue":"1\u20133","key":"10947_CR133","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejphar.2010.09.007","volume":"648","author":"T Minase","year":"2010","unstructured":"Minase T, Ishima T, Itoh K, Hashimoto K (2010) Potentiation of nerve growth factor-induced neurite outgrowth by the ROCK inhibitor Y-27632: A possible role of IP3 receptors. Eur J Pharmacol 648(1\u20133):67\u201373. https:\/\/doi.org\/10.1016\/j.ejphar.2010.09.007","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10947_CR134","doi-asserted-by":"publisher","first-page":"e59888","DOI":"10.1371\/journal.pone.0059888","volume":"8","author":"X Feng","year":"2013","unstructured":"Feng X, Liang N, Zhu D, Gao Q, Peng L, Dong H, Yue Q, Liu H, Bao L, Zhang J, Hao J, Gao Y, Yu X, Sun J (2013) Resveratrol inhibits \u03b2-Amyloid-Induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathway. PLoS ONE 8(3):e59888. https:\/\/doi.org\/10.1371\/journal.pone.0059888","journal-title":"PLoS ONE"},{"issue":"11","key":"10947_CR135","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.3390\/molecules29112616","volume":"29","author":"I G\u00f3ral","year":"2024","unstructured":"G\u00f3ral I, Wichur T, S\u0142ugocka E, Gody\u0144 J, Sza\u0142aj N, Zar\u0119ba P, G\u0142uch-Lutwin M, Mordyl B, Panek D, Wi\u0119ckowska A (2024) Connecting GSK-3\u03b2 inhibitory activity with IKK-\u03b2 or ROCK-1 inhibition to target Tau aggregation and neuroinflammation in alzheimer\u2019s Disease\u2014Discovery, in vitro and in cellulo activity of Thiazole-Based inhibitors. Molecules 29(11):2616. https:\/\/doi.org\/10.3390\/molecules29112616","journal-title":"Molecules"},{"issue":"49","key":"10947_CR136","doi-asserted-by":"publisher","first-page":"19086","DOI":"10.1523\/jneurosci.2508-13.2013","volume":"33","author":"JH Herskowitz","year":"2013","unstructured":"Herskowitz JH, Feng Y, Mattheyses AL, Hales CM, Higginbotham LA, Duong DM, Montine TJ, Troncoso JC, Thambisetty M, Seyfried NT, Levey AI, Lah JJ (2013) Pharmacologic Inhibition of ROCK2 suppresses amyloid-\u0392 production in an alzheimer\u2019s disease mouse model. J Neurosci 33(49):19086\u201319098. https:\/\/doi.org\/10.1523\/jneurosci.2508-13.2013","journal-title":"J Neurosci"},{"key":"10947_CR137","doi-asserted-by":"publisher","unstructured":"Yu J, Li Y, Liu C, Wang Q, Gu Q, Wang H, Zhang G, Xiao B, Ma C (2017) Multitarget therapeutic effect of fasudil in APP\/PS1transgenic mice. CNS & Neurological Disorders - Drug Targets, 16(2), 199\u2013209. https:\/\/doi.org\/10.2174\/1871527315666160711104719","DOI":"10.2174\/1871527315666160711104719"},{"key":"10947_CR138","doi-asserted-by":"publisher","first-page":"107314","DOI":"10.1016\/j.compbiolchem.2020.107314","volume":"87","author":"L Song","year":"2020","unstructured":"Song L, Zhu C, Zheng W, Lu D, Jiao H, Zhao R, Bao Z (2020) Computational systematic selectivity of the Fasalog inhibitors between ROCK-I and ROCK-II kinase isoforms in alzheimer\u2019s disease. Comput Biol Chem 87:107314. https:\/\/doi.org\/10.1016\/j.compbiolchem.2020.107314","journal-title":"Comput Biol Chem"},{"key":"10947_CR139","doi-asserted-by":"publisher","unstructured":"Collu R, Yin Z, Giunti E, Daley S, Chen M, Morin P, Killick R, Wong STC, Xia W (2024) Effect of the ROCK inhibitor fasudil on the brain proteomic profile in the Tau Transgenic mouse model of alzheimer\u2019s disease. Front Aging Neurosci 16. https:\/\/doi.org\/10.3389\/fnagi.2024.1323563","DOI":"10.3389\/fnagi.2024.1323563"},{"key":"10947_CR140","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv-2025-340h4","author":"L Franco","year":"2025","unstructured":"Franco L, Rodrigues D, Baumart G, Gomes F, Lima L, Fraga CA, Pinheiro P (2025) Drug repurposing by virtual screening: identification of new already approved ROCK inhibitors as promising drugs to target neurodegeneration. ChemRxiv. https:\/\/doi.org\/10.26434\/chemrxiv-2025-340h4","journal-title":"ChemRxiv"},{"issue":"1","key":"10947_CR141","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/acn3.19","volume":"1","author":"JH Lee","year":"2013","unstructured":"Lee JH, Zheng Y, Bornstadt D, Wei Y, Balcioglu A, Daneshmand A, Yalcin N, Yu E, Herisson F, Atalay YB, Kim MH, Ahn Y, Balkaya M, Sweetnam P, Schueller O, Poyurovsky MV, Kim H, Lo EH, Furie KL, Ayata C (2013) SelectiveROCK2 Inhibition in focal cerebral ischemia. Ann Clin Transl Neurol 1(1):2\u201314. https:\/\/doi.org\/10.1002\/acn3.19","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10947-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10947-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10947-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:02:30Z","timestamp":1766898150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10947-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":141,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10947"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10947-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"\u00a0NA.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of participant"}},{"value":"NA.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publish"}}],"article-number":"846"}}